108 related articles for article (PubMed ID: 2962910)
1. Continuous, high-dose progestogen treatment of endometrial cancer.
Szarvas Z; Zsolnai B; Gimes G; Hidvégi J
Gynecol Obstet Invest; 1987; 24(4):262-6. PubMed ID: 2962910
[TBL] [Abstract][Full Text] [Related]
2. [Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma].
Szarvas Z; Zsolnai B; Gimes G; Hidvégi J
Morphol Igazsagugyi Orv Sz; 1985 Oct; 25(4):253-60. PubMed ID: 2933583
[No Abstract] [Full Text] [Related]
3. Effect of progestogen (Depo-Provera) on annulate lamellae in endometrial carcinoma.
Szarvas Z; Zsolnai B
Acta Chir Hung; 1984; 25(4):269-76. PubMed ID: 6240879
[TBL] [Abstract][Full Text] [Related]
4. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Thurzó L
Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
[TBL] [Abstract][Full Text] [Related]
5. [Surface changes in endometrial cancer under the effect of large doses of progestogen (Depo-Provera)].
Szarvas Z; Zsolnai B
Morphol Igazsagugyi Orv Sz; 1984 Apr; 24(2):92-9. PubMed ID: 6717452
[No Abstract] [Full Text] [Related]
6. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
Thurzó L; Sas M; Falkay G
Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
[No Abstract] [Full Text] [Related]
7. Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.
Lindahl B; Willén R
Anticancer Res; 1991; 11(1):403-6. PubMed ID: 1826823
[TBL] [Abstract][Full Text] [Related]
8. Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy?
Lane G; Siddle NC; Ryder TA; Pryse-Davies J; King RJ; Whitehead MI
Fertil Steril; 1986 Mar; 45(3):345-52. PubMed ID: 3005052
[TBL] [Abstract][Full Text] [Related]
9. Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.
Luukkainen T; Karjalainen O
Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):581-5. PubMed ID: 5510182
[No Abstract] [Full Text] [Related]
10. Cytochemical examinations of Ca, cytochrome oxidase and succinate dehydrogenase enzymes in endometrium carcinomatous tissue after high dose progestogen treatment.
Szarvas Z; Balogh I; Patai K
Acta Morphol Hung; 1988; 36(3-4):177-83. PubMed ID: 2855777
[TBL] [Abstract][Full Text] [Related]
11. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
Feng YJ; Zhang XY
Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
[TBL] [Abstract][Full Text] [Related]
12. [Cell surface changes after high-dosage progesterone treatment in endometrial carcinoma].
Szarvas Z; Zsolnai B
Zentralbl Gynakol; 1984; 106(14):1010-7. PubMed ID: 6239468
[TBL] [Abstract][Full Text] [Related]
13. Immunohistological localization of pregnancy-associated endometrial alpha 2-globulin (alpha 2-PEG) in endometrial adenocarcinoma and effect of medroxyprogesterone acetate.
Wood PL; Waites GT; MacVicar J; Davidson AC; Walker RA; Bell SC
Br J Obstet Gynaecol; 1988 Dec; 95(12):1292-8. PubMed ID: 2975952
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of progestogens in the primary treatment of endometrial carcinoma.
Macdonald RR; Thorogood J; Mason MK
Br J Obstet Gynaecol; 1988 Feb; 95(2):166-74. PubMed ID: 2964861
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer.
Lewis GC; Slack NH; Mortel R; Bross ID
Gynecol Oncol; 1974 Aug; 2(2-3):368-76. PubMed ID: 4616883
[No Abstract] [Full Text] [Related]
16. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant gestagen therapy in stage I endometrial cancer].
Lahousen M; Pickel H
Zentralbl Gynakol; 1988; 110(16):1013-7. PubMed ID: 2973195
[TBL] [Abstract][Full Text] [Related]
18. Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma.
Piver MS; Barlow JJ; Lurain JR; Blumenson LE
Cancer; 1980 Jan; 45(2):268-72. PubMed ID: 6985833
[TBL] [Abstract][Full Text] [Related]
19. [Therapy with gestagens in hyperplastic changes of the endometrium].
Griesinger R; Schindler AE
Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):690-2. PubMed ID: 2948865
[TBL] [Abstract][Full Text] [Related]
20. [Experiences with Depo-Provera (medroxyprogesterone) in the treatment of kidney tumors].
Balogh F; Romics I
Z Urol Nephrol; 1987 Aug; 80(8):449-53. PubMed ID: 2961162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
